Clinical Trials Browser

Phase 1/2 × Has results × siremadlin × Clear all

NCT05447663 2025-05-16

A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Phase 1/2 Terminated

8 enrolled 14 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute